Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-5
|
Results: 5
Characterization of clotting factor IX in plasma-derived preparations by electrophoretic techniques
Authors:
Pock, K Buchacher, A Rizzi, A Josic, D
Citation:
K. Pock et al., Characterization of clotting factor IX in plasma-derived preparations by electrophoretic techniques, J CHROMAT A, 921(1), 2001, pp. 57-67
Vitronectin in clotting factor IX concentrates
Authors:
Josic, D Kannicht, C Loster, K Pock, K Iberer, G Buchacher, A
Citation:
D. Josic et al., Vitronectin in clotting factor IX concentrates, HAEMOPHILIA, 7(3), 2001, pp. 250-257
Use of high-resolution techniques for the characterization of clotting factor VIII
Authors:
Pock, K Rizzi, A Josic, D
Citation:
K. Pock et al., Use of high-resolution techniques for the characterization of clotting factor VIII, J CHROMAT A, 852(1), 1999, pp. 175-188
Development of medical products based on human plasma
Authors:
Josic, D Pock, K
Citation:
D. Josic et K. Pock, Development of medical products based on human plasma, FOOD TECH B, 37(1), 1999, pp. 51-63
Degradation products of factor VIII which can lead to increased immunogenicity
Authors:
Josic, D Buchacher, A Kannicht, C Lim, YP Loster, K Pock, K Robinson, S Schwinn, H Stadler, M
Citation:
D. Josic et al., Degradation products of factor VIII which can lead to increased immunogenicity, VOX SANGUIN, 77, 1999, pp. 90-99
Risultati:
1-5
|